Results 211 to 220 of about 68,999 (229)

A Randomized clinical trial evaluating the impact on survival and quality of life of <sup>177</sup>Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217). [PDF]

open access: yesBMC Cancer
Capdevila J   +34 more
europepmc   +1 more source

Carcinoid Heart Disease: A Classic One, But Not Always Remembered. [PDF]

open access: yesCureus
Ramírez-Rangel P   +4 more
europepmc   +1 more source

Insulinoma with suspected mutant somatostatin receptor expression according to histological examination. [PDF]

open access: yesClin Case Rep
Onish S   +10 more
europepmc   +1 more source

Response of circulating immunoreactive somatostatin to nutritional stimuli in normal subjects.

open access: bronze, 1981
Erica Penman   +6 more
openalex  

Somatostatin Receptor-Directed Theranostics in Esthesioneuroblastoma. [PDF]

open access: yesClin Nucl Med
Zhi Y   +11 more
europepmc   +1 more source

[89Zr]Zr-DFO-TOC: a novel radiopharmaceutical for PET imaging of somatostatin receptor positive neuroendocrine tumors. [PDF]

open access: yesEJNMMI Radiopharm Chem
Sanwick AM   +5 more
europepmc   +1 more source

Evaluation of the Real-Life Efficacy and Safety of the Treatment with Lutetium-177 Dotatate for Metastatic Neuroendocrine Tumors. [PDF]

open access: yesJ Clin Med
Campos Ramírez SE   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy